CAPE TOWN, Feb 5 (Reuters) – South Africa’s health ministry said on Friday that the government had signed off on a term sheet for 9 million doses of Johnson & Johnson’s COVID-19 vaccine at $10 a dose.
The ministry said in a presentation in parliament that one of the conditions for the J&J vaccine was the establishment of a no-fault compensation system for adverse events.
It added that Moderna had offered the country 200,000 doses of its COVID-19 vaccine priced at $30-$42 a dose in the second quarter, with more doses available in the third quarter. (Reporting by Wendell Roelf Writing by Alexander Winning Editing by Olivia Kumwenda-Mtambo)
(c) Copyright Thomson Reuters 2021. Click For Restrictions – https://agency.reuters.com/en/copyright.html
Get the best of CNBC Africa sent straight to your inbox with breaking business news, insights and updates from experts across the continent. Sign up here.